Inventor · disambiguated record
Dennis J. Selkoe
Also filed as: SELKOE DENNIS · SELKOE DENNIS J
7 granted patents·7 pending applications·805 citations·filing 1989–2022
89Inventor score
Files withBRIGHAM & WOMENS HOSPITAL4BRIGHAM & WOMENS HOSPITAL INC2ELAN PHARM INC2RINGE DAGMAR2ATHENA NEUROSCIENCES1
Top patents by PatentIndex Score
14 records- 0196US5766846AMethods of screening for compounds which inhibit soluble β-amyloid peptide productionATHENA NEUROSCIENCES·Filed 1993·Granted Jun 16, 1998·308 cites·21 claims
- 0294US5837672AMethods and compositions for the detection of soluble β-amyloid peptideATHENA NEUROSCIENCES INC·Filed 1995·Granted Nov 17, 1998·185 cites·14 claims
- 0393US6284221B1Method for identifying β-amyloid peptide production inhibitorsELAN PHARM INC·Filed 1996·Granted Sep 4, 2001·132 cites·9 claims
- 0492US5262332ADiagnostic method for Alzheimer's disease: examination of non-neural tissueBRIGHAM & WOMENS HOSPITAL·Filed 1989·Granted Nov 16, 1993·103 cites·20 claims
- 0585US6610493B1Screening compounds for the ability to alter the production of amyloid-β peptideBRIGHAM & WOMENS HOSPITAL·Filed 1996·Granted Aug 26, 2003·69 cites·21 claims
- 0676US6696488B2(Hydroxyethyl)ureas as inhibitors of alzheimer's β-amyloid productionBRIGHAM & WOMENS HOSPITAL·Filed 2001·Granted Feb 24, 2004·8 cites·3 claims
- 0760US2024358805A1Methods and materials to treat neurodegenerative diseaseBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Application pending·0 cites
- 0849US7993627B2Methods for determining whether a compound alters the amount of at least one αβ (X-41) peptide and the amount of either total αβ or at least one αβ (X-40) peptide produced by a non-human mammalELAN PHARM INC·Filed 2002·Granted Aug 9, 2011·0 cites·5 claims
- 0947US2023107034A1Neutralizing anti-amyloid beta antibodies for the treatment of alzheimer's diseaseBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Application pending·0 cites
- 1045US2005123553A1Amyloid beta-peptide and methods of useFiled 2004·Application pending·0 cites
- 1143US2013289022A1Tetrameric alpha-synuclein and use thereofRINGE DAGMAR·Filed 2011·Application pending·0 cites
- 1243US2013309690A1Tetrameric alpha-synuclein as biomarkersRINGE DAGMAR·Filed 2011·Application pending·0 cites
- 1340US2014243374A1Novel SulfonamidesBRIGHAM & WOMENS HOSPITAL·Filed 2012·Application pending·0 cites
- 1437US2013310384A1Sulfonamide-Containing CompoundsAUGELLI-SZAFRAN CORINNE E·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →